Skip to main content

Our low-carbon commitment to a sustainable future


Growing awareness of the urgency of climate change has led us, like others, to question our environmental impact and our contribution to the ecological transition.

In 2023, we therefore decided to reducing our carbon footprint a major focus of our CSR strategy, which is itself at the heart of the Peters Surgical Group’s strategic plan.

After raising the awareness of all our employees through educational workshops (Climate Fresk), this year we took an important and essential first step with the completion of our carbon footprint assessment. This is not only a step towards transparency, but also the starting point for a proactive path towards a more sustainable future.

We have made a commitment to approach the completion of our carbon footprint with rigour.

To ensure that this essential step is carried out professionally, we have chosen the Aktio reference platform. In addition to the tool, Aktio’s carbon experts supported us throughout the process, from data collection to the production of a certified Carbone Footprint report, thereby ensuring its integrity.


Our carbon footprint is more than just an assessment of greenhouse gas emissions from our main production site in France. It encompasses our entire organization, including the Group’s supply chains, by integrating the three scopes defined by the GHG (Greenhouse Gas) Protocol:

Scope 1: Includes direct greenhouse gas emissions, such as those from our production facilities and company vehicles.

Scope 2: Includes indirect emissions linked to the production of electricity or heat that we consume. We have taken into account all of our electricity consumption to ensure a complete assessment.

Scope 3: The most complex and comprehensive scope, covering indirect emissions linked to our activities, such as emissions from our supply chain, our suppliers and the use of our products by customers.

Carrying out our assessment of the three scopes has been enlightening. It has enabled us to quantify our GHG emissions precisely and to understand the major sources of these emissions, with scope 3 now accounting for 75% of them, and with a predominance of emissions linked to the purchase of materials, transport and energy.


Now that we have a clear view of our carbon footprint, we are resolutely committed to reducing it. The detailed results of our carbon assessment will provide us with a solid basis for defining and implementing a low-carbon trajectory, with reduction targets that we hope to align with the recommendations of the Science-Based Targets Initiative (SBTI). In parallel with the implementation of this strategy, we have already rolled out concrete measures to optimize our supply chain, we are investing in projects to reduce our direct emissions at our various production sites (energy optimization, including the use of renewable energy) and we are implementing a responsible purchasing approach with our suppliers to encourage sustainable practices throughout our supply chain. Finally, we continue to make our employees aware of the importance of our approach and actively involve them, particularly through ambassador committees, who are encouraged to develop and implement new initiatives.


We are convinced that our low-carbon approach is an investment in a more sustainable future for our company, our employees, our customers and the planet. We encourage all those involved in healthcare to join us in this collective quest for a better world, and thank the French Association of Surgery and Professor Pessaux for their commitment.


     Marie Compagnon-Riobé

     Chief Sustainability and Regulatory Officer